Reduced Fluid Volume for Pediatric Trauma
Trial Summary
What is the purpose of this trial?
This study is designed to help decide how much intravenous (IV) fluid should be given to pediatric trauma patients. No standard currently exists for managing fluids in critically ill pediatric trauma patients, and many fluid strategies are now in practice. For decades, trauma patients got high volumes of IV fluid. Recent studies in adults show that patients actually do better by giving less fluid. The investigators do not know if this is true in children and this study is designed to answer that question and provide guidelines for IV fluid management in children after trauma.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Reduced Fluid, Limited Fluid Resuscitation, Restrictive Fluid Management for pediatric trauma?
Is reduced fluid volume treatment generally safe for children?
How does the Reduced Fluid treatment differ from other treatments for pediatric trauma?
Reduced Fluid treatment, also known as Limited Fluid Resuscitation, is unique because it involves giving less fluid to children with trauma compared to traditional methods. This approach aims to prevent fluid overload, which can lead to complications and longer hospital stays, by carefully managing the amount of fluid given during treatment.123510
Research Team
Vincent P Duron, MD
Principal Investigator
Columbia University
Eligibility Criteria
This trial is for children aged 6 months to less than 15 years who have experienced trauma and are admitted to the PICU from the ER or OR, or transferred from another facility's ED within 12 hours. It excludes those with chronic kidney disease, certain heart conditions, hypotension requiring vasopressors, massive transfusion protocol initiated, traumatic brain injury, or diseases affecting blood pressure and heart rate.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a liberal or restricted fluid management strategy
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Reduced Fluid (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
Dr. Katrina Armstrong
Columbia University
Chief Executive Officer
MD from Johns Hopkins University, MS in Epidemiology from Harvard School of Public Health
Dr. Katrina Armstrong
Columbia University
Chief Medical Officer
MD from Harvard Medical School
Childress Institute for Pediatric Trauma
Collaborator
Northwell Health
Collaborator
Michael Dowling
Northwell Health
Chief Executive Officer since 2002
Bachelor's and Master's degrees from University College Cork, Ireland
Dr. David Battinelli
Northwell Health
Chief Medical Officer since 2022
MD from Georgetown University School of Medicine
Cornell University
Collaborator
Matthew DeLisa
Cornell University
Chief Executive Officer since 2019
PhD in Chemical Engineering from Cornell University
Tami Magnus
Cornell University
Chief Medical Officer since 2015
MBA from Binghamton University
Johns Hopkins University
Collaborator
Theodore DeWeese
Johns Hopkins University
Chief Executive Officer since 2023
MD from an unspecified institution
Allen Kachalia
Johns Hopkins University
Chief Medical Officer since 2023
MD from an unspecified institution